The secondary objectives are to compare the time required to achieve optimal glycemic control and the rate of insulin therapy between the 2 groups, and to determine factors associated with the success of metformin PR treatment, such as prepregnancy BMI, degree of abnormalities of test results at the time of diagnosis, GDM risk factors, and other baseline characteristics. This evidence concerns the gene INS and gestational diabetes.